Skip to content

Rapid fibrosis progression in large proportion of HIV-positive gay men after acute HCV

US FDA approves nivolumab immunotherapy for liver cancer

Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection

Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV

Two-thirds of people with HIV/HCV co-infection in Southeast Asia in need of HCV therapy

Liver cirrhosis and decompensation still on the rise among people with hepatitis C

People with HIV/HCV co-infection at increased risk of kidney disease and bone disorders

Birth cohort screening and linkage to care for HCV treatment still weak in United States

Effective antiviral treatment reduces fatigue in people with chronic hepatitis C

Rasmus Thornhøj of Odense University Hospital presents findings from the FAT-HEP study. Photo by Liz Highleyman, hivandhepatitis.com